Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2005 2
2008 1
2009 2
2010 1
2011 1
2012 1
2013 3
2014 5
2015 4
2016 4
2017 7
2018 7
2019 7
2020 6
2021 8
2022 4
2023 8
2024 8
2025 6
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Consensus on diagnosis and management of Cushing's disease: a guideline update.
Fleseriu M, Auchus R, Bancos I, Ben-Shlomo A, Bertherat J, Biermasz NR, Boguszewski CL, Bronstein MD, Buchfelder M, Carmichael JD, Casanueva FF, Castinetti F, Chanson P, Findling J, Gadelha M, Geer EB, Giustina A, Grossman A, Gurnell M, Ho K, Ioachimescu AG, Kaiser UB, Karavitaki N, Katznelson L, Kelly DF, Lacroix A, McCormack A, Melmed S, Molitch M, Mortini P, Newell-Price J, Nieman L, Pereira AM, Petersenn S, Pivonello R, Raff H, Reincke M, Salvatori R, Scaroni C, Shimon I, Stratakis CA, Swearingen B, Tabarin A, Takahashi Y, Theodoropoulou M, Tsagarakis S, Valassi E, Varlamov EV, Vila G, Wass J, Webb SM, Zatelli MC, Biller BMK. Fleseriu M, et al. Among authors: geer eb. Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-875. doi: 10.1016/S2213-8587(21)00235-7. Epub 2021 Oct 20. Lancet Diabetes Endocrinol. 2021. PMID: 34687601 Free PMC article. Review.
Consensus on criteria for acromegaly diagnosis and remission.
Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S; Acromegaly Consensus Group. Giustina A, et al. Pituitary. 2024 Feb;27(1):7-22. doi: 10.1007/s11102-023-01360-1. Epub 2023 Nov 3. Pituitary. 2024. PMID: 37923946 Free PMC article.
Consensus on acromegaly therapeutic outcomes: an update.
Melmed S, di Filippo L, Fleseriu M, Mercado M, Karavitaki N, Gurnell M, Salvatori R, Tsagarakis S, Losa M, Maffei P, Pereira AM, Geer EB, Katznelson L, van der Lely AJ, Bollerslev J, Esposito D, Webb SM, Zatelli MC, Valassi E, Neggers S, Chanson P, Ho KKY, Ioachimescu AG, Biller BMK, Samson SL, Kaiser UB, Schilbach K, Luque RM, Casanueva FF, Shimon I, Boguszewski CL, Biermasz N, Colao A, Pirchio R, Lamberts SWJ, Kadioglu P, Buchfelder M, Frara S, Chiloiro S, Petersenn S, Gadelha MR, Puig-Domingo M, Luger A, Brue T, Beckers A, Ferone D, Clemmons DR, Greenman Y, Marazuela M, Mortini P, Strasburger CJ, Giustina A. Melmed S, et al. Among authors: geer eb. Nat Rev Endocrinol. 2025 Nov;21(11):718-737. doi: 10.1038/s41574-025-01148-2. Epub 2025 Aug 13. Nat Rev Endocrinol. 2025. PMID: 40804505 Review.
EndoBridge 2024: pearls and highlights.
Yildiz BO, Armeni E, Balodimou C, Biondi B, Ciudin A, Frühbeck G, Fuleihan GE, Geer EB, Gillard P, Gordon CM, Goulis D, Hammer GD, Höybye C, Langdahl BL, Laufer AB, van der Lely AJ, Macut D, Mader JK, McGowan B, Novac E, Pignatelli D, Pfeifer M, Radić L, Shah V, Stratakis CA, Treiber G, Vrachnis DN, Wilding J, Yazici D, Celik O. Yildiz BO, et al. Among authors: geer eb. Hormones (Athens). 2025 Dec;24(4):923-946. doi: 10.1007/s42000-025-00708-5. Epub 2025 Aug 6. Hormones (Athens). 2025. PMID: 40768135
Patient-Reported Outcomes in Endocrinology.
Geer EB. Geer EB. Endocrinol Metab Clin North Am. 2022 Dec;51(4):xv-xvi. doi: 10.1016/j.ecl.2022.06.001. Endocrinol Metab Clin North Am. 2022. PMID: 36244698 No abstract available.
Evaluating Patient-Reported Outcomes in Cushing's Syndrome.
Gumaste N, Shah L, Cheesman KC, Geer EB. Gumaste N, et al. Among authors: geer eb. Endocrinol Metab Clin North Am. 2022 Dec;51(4):691-707. doi: 10.1016/j.ecl.2022.05.002. Epub 2022 Sep 24. Endocrinol Metab Clin North Am. 2022. PMID: 36244687 Review.
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors.
Lin AL, Rudneva VA, Richards AL, Zhang Y, Woo HJ, Cohen M, Tisnado J, Majd N, Wardlaw SL, Page-Wilson G, Sengupta S, Chow F, Goichot B, Ozer BH, Dietrich J, Nachtigall L, Desai A, Alano T, Ogilive S, Solit DB, Bale TA, Rosenblum M, Donoghue MTA, Geer EB, Tabar V. Lin AL, et al. Among authors: geer eb. Acta Neuropathol. 2024 May 17;147(1):85. doi: 10.1007/s00401-024-02736-8. Acta Neuropathol. 2024. PMID: 38758238 Free PMC article.
Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors.
Lin AL, Rudneva V, Newton A, Majd NK, Magge R, Sengupta S, Goichot B, Piotrowski A, Gavrilovic I, Cooper O, Rosenblum M, Kaley T, Mellinghoff I, Young RJ, Donoghue MTA, Tabar V, Geer EB. Lin AL, et al. Among authors: geer eb. J Clin Endocrinol Metab. 2025 Oct 16;110(11):3066-3073. doi: 10.1210/clinem/dgaf178. J Clin Endocrinol Metab. 2025. PMID: 40109237 Free PMC article. Clinical Trial.
Prolactinoma through the female life cycle.
Cocks Eschler D, Javanmard P, Cox K, Geer EB. Cocks Eschler D, et al. Among authors: geer eb. Endocrine. 2018 Jan;59(1):16-29. doi: 10.1007/s12020-017-1438-7. Epub 2017 Nov 24. Endocrine. 2018. PMID: 29177641 Review.
74 results